5-METHYL HYDROGEN N-(4-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMATE
UNII VP8K3KXD2B
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-methyl Hydrogen N-(4-(2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-l-glutamate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VP8K3KXD2B.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1265908-64-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H23N5O6 KHRSEJRFFOKXIA-AWEZNQCLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-methyl Hydrogen N-(4-(2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-l-glutamate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.